Cefectra S 500mg/250mg Injection
Marketer
Serbia Molecules Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefectra S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under a doctor's guidance; complete the prescribed regimen, even with symptom improvement, as premature cessation may reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt medical assistance. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should seek medical counsel. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if experiencing somnolence or vertigo. Adequate rest, a balanced diet, and sufficient hydration contribute to faster recovery. Your physician may order blood work and diagnostic tests to monitor therapeutic response.
Uses of Cefectra S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cefectra S 500mg/250mg Injection:
This medication will be administered by your physician or their associate; self-medication is strictly prohibited.
Common Side effects of Cefectra S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefectra S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cefectra S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefectra S 500mg/250mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a broad-spectrum antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to multiply. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Cefectra S 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
Cefectra S 500mg/250mg injection is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Cefectra S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cefectra S 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefectra S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Cefectra S (500mg/250mg) requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Cefectra S (500mg/250mg) injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefectra S 500mg/250mg Injection :
Omitting a scheduled dose of Cefectra S 500mg/250mg Injection warrants immediate physician consultation.
Facts to Know About Cefectra S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently